ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 166588 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 166588; 2) Community: the network communities that were significantly associated with the response to NSC 166588; 3) Molecule: the relationships between components within communities and NSC 166588; 4) MDR: the compounds that were significantly associated with the NSC 166588.

NSC Compound Enrichment Correlation
NSC 711077 Null 0.0480633950058475 0.30072411
NSC 715407 Null 0.0480633950058475 0.39743616
NSC 717468 Null 0.0480633950058475 0.33071356
NSC 718781 Erlotinib hydrochloride 0.0480633950058475 -0.27620274
NSC 726089 11-(4-dimethylaminobenzyliden)-8-methoxy-5-methyl-11H-indolo [1,2-b]indazolium trifluoromethanesulfonate 0.0480633950058475 0.33125012
NSC 731704 1-[4-Ethoxycarbonyl)homopiperazine-1-yl]diazen-1-ium-1,2-dio late. 0.0480633950058475 0.41507227
NSC 743433 8-(4-{4-[6-(4-piperazinoquinazoline)-7-methoxy-2,3,5,11-atetrahydra-1H-benzo[e]pyrrolo[1,2-c][1,4]diazepin-5-one 0.0480633950058475 0.52129941
NSC 744688 Null 0.0480633950058475 0.36888436
NSC 752346 Null 0.0480633950058475 0.18530487
NSC 753377 3-[2-(1-methyl-1H-indol-3-yl)-1,3-thiazol-4-yl]-1-methyl-1H-pyrrolo[2,3-b]pyridine 0.0480633950058475 0.058385389
Total:144  Current:140    [First] [Prev] [Next] [Last]